Association between triglyceride-glucose-body mass index and risk of aortic stenosis progression in patients with non-severe aortic stenosis: a retrospective cohort study

Coffey S, Roberts-Thomson R, Brown A, Carapetis J, Chen M, Enriquez-Sarano M, Zühlke L, Prendergast BD. Global epidemiology of valvular heart disease. Nat Rev Cardiol. 2021;18(12):853–64.

Article  PubMed  Google Scholar 

Scalia IG, Farina JM, Padang R, Jokerst CE, Pereyra M, Mahmoud AK, Naqvi TZ, Chao CJ, Oh JK, Arsanjani R et al. Aortic valve calcium score by computed tomography as an adjunct to echocardiographic assessment-a review of clinical utility and applications. J Imaging 2023, 9(11).

Kanwar A, Thaden JJ, Nkomo VT. Management of patients with aortic valve stenosis. Mayo Clin Proc. 2018;93(4):488–508.

Article  PubMed  Google Scholar 

Pinto G, Fragasso G. Aortic valve stenosis: drivers of disease progression and drug targets for therapeutic opportunities. Expert Opin Ther Targets. 2022;26(7):633–44.

Article  CAS  PubMed  Google Scholar 

Lindman BR, Merryman WD. Unloading the stenotic path to identifying medical therapy for calcific aortic valve disease: barriers and opportunities. Circulation. 2021;143(15):1455–7.

Article  PubMed  PubMed Central  Google Scholar 

Généreux P, Sharma RP, Cubeddu RJ, Aaron L, Abdelfattah OM, Koulogiannis KP, Marcoff L, Naguib M, Kapadia SR, Makkar RR, et al. The mortality burden of untreated aortic stenosis. J Am Coll Cardiol. 2023;82(22):2101–9.

Article  PubMed  Google Scholar 

Li SX, Patel NK, Flannery LD, Selberg A, Kandanelly RR, Morrison FJ, Kim J, Tanguturi VK, Crousillat DR, Shaqdan AW, et al. Trends in utilization of aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol. 2022;79(9):864–77.

Article  PubMed  Google Scholar 

Goody PR, Hosen MR, Christmann D, Niepmann ST, Zietzer A, Adam M, Bönner F, Zimmer S, Nickenig G, Jansen F. Aortic valve stenosis: from basic mechanisms to novel therapeutic targets. Arterioscler Thromb Vasc Biol. 2020;40(4):885–900.

Article  CAS  PubMed  Google Scholar 

Alkhouli M, Sievert H, Rihal CS. Device embolization in structural heart interventions: incidence, outcomes, and retrieval techniques. JACC Cardiovasc Interv. 2019;12(2):113–26.

Article  PubMed  Google Scholar 

Boskovski MT, Gleason TG. Current therapeutic options in aortic stenosis. Circ Res. 2021;128(9):1398–417.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Ding X, Hua B, Liu Q, Gao H, Chen H, Zhao XQ, Li W, Li H. High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction. Nutr Metab Cardiovasc Dis. 2020;30(12):2351–62.

Article  CAS  PubMed  Google Scholar 

Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, Jacques-Camarena O, Rodríguez-Morán M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51.

Article  CAS  PubMed  Google Scholar 

Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.

Article  PubMed  Google Scholar 

Hou XZ, Lv YF, Li YS, Wu Q, Lv QY, Yang YT, Li LL, Ye XJ, Yang CY, Wang MS, et al. Association between different insulin resistance surrogates and all-cause mortality in patients with coronary heart disease and hypertension: NHANES longitudinal cohort study. Cardiovasc Diabetol. 2024;23(1):86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cai W, Xu J, Wu X, Chen Z, Zeng L, Song X, Zeng Y, Yu F. Association between triglyceride-glucose index and all-cause mortality in critically ill patients with ischemic stroke: analysis of the MIMIC-IV database. Cardiovasc Diabetol. 2023;22(1):138.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, Ma J, Zhao Y, Zhu W, Wang J. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi W, Xing L, Jing L, Tian Y, Yan H, Sun Q, Dai D, Shi L, Liu S. Value of triglyceride-glucose index for the estimation of ischemic stroke risk: insights from a general population. Nutr Metab Cardiovasc Dis. 2020;30(2):245–53.

Article  CAS  PubMed  Google Scholar 

Guo W, Zhu W, Wu J, Li X, Lu J, Qin P, Zhu C, Xu N, Zhang Q. Triglyceride glucose index is associated with arterial stiffness and 10-year cardiovascular disease risk in a Chinese population. Front Cardiovasc Med. 2021;8:585776.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su WY, Chen SC, Huang YT, Huang JC, Wu PY, Hsu WH, Lee MY. Comparison of the effects of fasting glucose, hemoglobin A(1c), and triglyceride-glucose index on cardiovascular events in type 2 diabetes mellitus. Nutrients 2019, 11(11).

Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: an analysis of the 2007–2010 Korean national health and nutrition examination survey. PLoS ONE. 2019;14(3):e0212963.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Yang W, Jiang X. Association between triglyceride-glucose index and hypertension: a meta-analysis. Front Cardiovasc Med. 2021;8:644035.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang X, Liu J, Cheng Z, Zhong Y, Chen X, Song W. Triglyceride glucose-body mass index and the risk of diabetes: a general population-based cohort study. Lipids Health Dis. 2021;20(1):99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang R, Dai L, Zhong Y, Xie G. Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population. Lipids Health Dis. 2021;20(1):77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao D, Sun H, Chen L, Li X, Huo H, Zhou G, Zhang M, He B. Assessment of six surrogate insulin resistance indexes for predicting cardiometabolic multimorbidity incidence in Chinese middle-aged and older populations: insights from the China health and retirement longitudinal study. Diabetes Metab Res Rev. 2024;40(1):e3764.

Article  CAS  PubMed  Google Scholar 

Huo RR, Zhai L, Liao Q, You XM. Changes in the triglyceride glucose-body mass index estimate the risk of stroke in middle-aged and older Chinese adults: a nationwide prospective cohort study. Cardiovasc Diabetol. 2023;22(1):254.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tao S, Yu L, Li J, Huang L, Xue T, Yang D, Huang X, Meng C. Multiple triglyceride-derived metabolic indices and incident cardiovascular outcomes in patients with type 2 diabetes and coronary heart disease. Cardiovasc Diabetol. 2024;23(1):359.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yan J, Zhang MZ, He QQ. Association of changes and cumulative measures of triglyceride-glucose index-body mass index with hypertension risk: a prospective cohort study. BMC Public Health. 2024;24(1):2652.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li W, Shen C, Kong W, Zhou X, Fan H, Zhang Y, Liu Z, Zheng L. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23(1):292.

Article  PubMed  PubMed Central  Google Scholar 

Wang R, Cheng X, Tao W. Association between triglyceride glucose body mass index and cardiovascular disease in adults: evidence from NHANES 2011–2020. Front Endocrinol. 2024;15:1362667.

Article 

留言 (0)

沒有登入
gif